Publications
2 shownTranscriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.
PURPOSE: For hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer (MBC), first-line cyclin-dependent kinase 4/6 inhib...
Frequent Co-Authors
Researcher Info
- h-index
- 0
- Publications
- 2
- Citations
- 0
External Links
Identifiers
- ORCID
- 0000-0001-7772-1437
Impact Metrics
h-index
0
h-index: Number of publications with at least h citations each.